In a recent phase I/II trial, 11 patients with R/R CD19+ non-Hodgkin lymphoma or chronic lymphocytic leukemia were administered with HLA-mismatched anti-CD19 CAR NK cells derived from cord blood (NCT03056339). This evidence concerns the gene CD19 and non-Hodgkin lymphoma.